Psychemedics

Psychemedics Intangible Assets

The Intangible Assets of Psychemedics (PMDI) as of Oct 16, 2026 is 400,000.00 USD. In the previous year, Intangible Assets was 500,000.00 USD — a change of -20.00% (lower).

Intangible Assets

400,000.00USD

YoY

-20.00%

Last updated:

Intangible Assets of Psychemedics is 2024 400,000.00 USD. Intangible Assets of Psychemedics was 2023 500,000.00 USD. It decreases by -20.00% lower compared to the previous year.

The Psychemedics Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
710,000.00 USD
Jan 1, 2018
740,000.00 USD
Jan 1, 2019
740,000.00 USD
Jan 1, 2020
700,000.00 USD
Jan 1, 2021
700,000.00 USD
Jan 1, 2022
600,000.00 USD
Jan 1, 2023
500,000.00 USD
Jan 1, 2024
400,000.00 USD
The Psychemedics Intangible Assets history
YEARIntangible AssetsYoY
400,000.00USD-20.00%
500,000.00USD-16.67%
600,000.00USD-14.29%
700,000.00USD0.00%
700,000.00USD-5.41%
740,000.00USD0.00%
740,000.00USD+4.23%
710,000.00USD-1.39%
720,000.00USD+7.46%
670,000.00USD+1.52%
660,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Psychemedics Stock analysis

What does Psychemedics do? Psychemedics Corp, trading under the ticker PMDI, is a U.S.-based company headquartered in Acton, Massachusetts. The company specializes in drug testing services, focusing on the analysis of hair samples to detect the presence of drugs of abuse. With 204 full-time employees, Psychemedics operates within the Health Care sector, specifically in the Health Care industry. The company's primary service involves conducting drug tests and reporting results to clients, including training for sample collection and storage of positive samples for a fee per unit tested. Its testing methodology provides detailed information on the approximate amount of drug ingested and historical data on drug use patterns over time. Psychemedics went public on January 22, 1987, marking the beginning of its journey as a publicly traded entity. The company's website, https://www.psychemedics.com/, serves as a primary source of information for its services and operations. While the company's core business is centered on drug testing, it does not disclose specific product names or additional services beyond the scope of hair sample analysis and reporting. Psychemedics maintains a presence in the U.S. market, with its operations primarily focused on providing reliable and detailed drug testing solutions to its clients. The company's approach to testing emphasizes both the immediate detection of drug use and the ability to track usage patterns over extended periods, offering a comprehensive service for its customers. Psychemedics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Psychemedics stock

Intangible Assets of Psychemedics is 400,000.00 USD in 2024.

Intangible Assets of Psychemedics changed from 500,000.00 USD to 400,000.00 USD, representing a -20.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Psychemedics since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Psychemedics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Psychemedics

All Key Metrics — Psychemedics